Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nautilus Biotechnology Inc (NAUT)

Nautilus Biotechnology Inc (NAUT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 252,610
  • Shares Outstanding, K 126,305
  • Annual Sales, $ 0 K
  • Annual Income, $ -70,780 K
  • EBIT $ -71 M
  • EBITDA $ -68 M
  • 60-Month Beta 1.48
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.46

Options Overview Details

View History
  • Implied Volatility 131.71% (-140.12%)
  • Historical Volatility 94.64%
  • IV Percentile 3%
  • IV Rank 0.45%
  • IV High 771.69% on 05/12/25
  • IV Low 128.79% on 11/11/25
  • Expected Move (DTE 22) 0.68 (34.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 29
  • Volume Avg (30-Day) 48
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 1,735
  • Open Int (30-Day) 3,199
  • Expected Range 1.32 to 2.68

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.13
  • Growth Rate Est. (year over year) +768,561.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.78 +12.36%
on 12/17/25
2.35 -14.89%
on 11/28/25
-0.07 (-3.38%)
since 11/24/25
3-Month
0.72 +179.21%
on 09/25/25
2.54 -21.26%
on 11/20/25
+1.28 (+177.74%)
since 09/24/25
52-Week
0.62 +222.58%
on 09/04/25
2.54 -21.26%
on 11/20/25
+0.27 (+15.61%)
since 12/24/24

Most Recent Stories

More News
Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging

• Buck Institute’s deployment of Nautilus’ instrument generates tau proteoform data, providing external validation of the company’s next-generation single-molecule proteomics platform  • Joint...

NAUT : 2.00 (+2.56%)
Nautilus Biotechnology Reports Third Quarter 2025 Financial Results

SEATTLE, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial...

NAUT : 2.00 (+2.56%)
Nautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025

SEATTLE, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report...

NAUT : 2.00 (+2.56%)
Nautilus Biotechnology to Participate in Upcoming September Investor Conferences

SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company...

NAUT : 2.00 (+2.56%)
Nautilus Biotechnology Reports Second Quarter 2025 Financial Results

SEATTLE, July 31, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial...

NAUT : 2.00 (+2.56%)
Nautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule Proteomics

• Allen Institute to employ Iterative Mapping, Nautilus’ single-molecule proteomics method, to investigate connection between tau protein and Alzheimer’s disease • Agreement links the...

NAUT : 2.00 (+2.56%)
Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025

SEATTLE, July 15, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome,...

NAUT : 2.00 (+2.56%)
Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

NAUT : 2.00 (+2.56%)
Nautilus Biotechnology Reports First Quarter 2025 Financial Results

NAUT : 2.00 (+2.56%)
Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025

NAUT : 2.00 (+2.56%)

Business Summary

Nautilus Biotechnology Inc. is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus Biotechnology Inc., formerly known as Arya Sciences Acquisition Corp III, is based in SEATTLE.

See More

Key Turning Points

3rd Resistance Point 2.09
2nd Resistance Point 2.05
1st Resistance Point 2.02
Last Price 2.00
1st Support Level 1.95
2nd Support Level 1.91
3rd Support Level 1.88

See More

52-Week High 2.54
Last Price 2.00
Fibonacci 61.8% 1.81
Fibonacci 50% 1.58
Fibonacci 38.2% 1.35
52-Week Low 0.62

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar